Virtual Library

Start Your Search

  • WCLC 2017

    18th World Conference on Lung Cancer

    Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan

    Presentation Date(s):  
    • Oct 15 - 18, 2017
    • Total Presentations: 2295

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Download PDF of the Conference Program: Click Here.
    Onsite Conference Program Addendum (17/10/2017): Click Here.
    Download PDF of the Abstract Book: Click Here.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P1.03 - Chemotherapy/Targeted Therapy

    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
    • Presentations: 53
    • Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P1.03-005 - Phase 2 Study of Ceritinib in Patients with ALK+ NSCLC with Prior Alectinib Treatment in Japan: ASCEND-9

      09:30 - 09:30  |  Presenter: Hidehito Horinouchi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.03 - Chemotherapy/Targeted Therapy

    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
    • Presentations: 59
    • Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P2.03-036 - Comparing the Efficacy/Toxicity of Osimertinib and First Line EGFR-TKI by Individual Patient Analysis

      09:30 - 09:30  |  Presenter: Shoko Narita

      • Abstract

      Loading...

    • +

      P2.03-048 - Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib

      09:30 - 09:30  |  Presenter: Yuki Shinno

      • Abstract

      Loading...

  • +

    P2.07 - Immunology and Immunotherapy

    • Type: Poster Session with Presenters Present
    • Track: Immunology and Immunotherapy
    • Presentations: 65
    • Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P2.07-011 - Long Follow up from Phase I Study of Nivolumab and Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Shintaro Kanda

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA 10 - Immunotherapy I

    • Type: Mini Oral
    • Track: Immunology and Immunotherapy
    • Presentations: 12
    • Moderators:S. Wang
    • Coordinates: 10/17/2017, 11:00 - 12:30, Room 303 + 304
  • +

    MA 16 - Mediastinal, Tracheal and Esophageal Tumor: Multimodality Approaches

    • Type: Mini Oral
    • Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
    • Presentations: 15
    • Moderators:K. Shibuya
    • Coordinates: 10/17/2017, 15:45 - 17:30, Room 313 + 314
  • +

    P3.02 - Biology/Pathology

    • Type: Poster Session with Presenters Present
    • Track: Biology/Pathology
    • Presentations: 106
    • Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P3.02-041 - EGFR Amplification Mediates Resistance to TAS121, A Third-Generation EGFR-TKI, in EGFR T790M-Positive Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Presenter: Sho Watanabe

      • Abstract

      Loading...

  • +

    P3.04 - Clinical Design, Statistics and Clinical Trials

    • Type: Poster Session with Presenters Present
    • Track: Clinical Design, Statistics and Clinical Trials
    • Presentations: 15
    • Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P3.04-002 - A Randomized Phase II Study of Carboplatin plus Nab-Paclitaxel with or Without Nintedanib for NSCLC with IPF (J-SONIC): Trial in Progress

      09:30 - 09:30  |  Presenter: Kohei Otsubo

      • Abstract

      Loading...

  • +

    MS 23 - Management of N2 NSCLC: What “Operable” Means?

    • Type: Mini Symposium
    • Track: Locally Advanced NSCLC
    • Presentations: 6
    • Moderators:G. Lyons
    • Coordinates: 10/18/2017, 14:30 - 16:15, F203 + F204 (Annex Hall)